Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Built on the proud heritage of F-D-C Reports, Windhover Information and Medtech Insight, Elsevier Business Intelligence is a leader in the field of healthcare industry information.
Elsevier Business Intelligence Publications and Products
BioPharma Focus
"The Pink Sheet" | "The Pink Sheet” DAILY | IN VIVO | PharmAsia News | Start-Up | Pharmaceutical Approvals Monthly | The RPM Report | "The Gold Sheet" | Windhover Conferences & Webinars | INTELEOS | Strategic Transactions | Transaction Tracker | The IN VIVO Blog | BioPharma Today | Health News Daily
Medical Device Focus
"The Gray Sheet" | IN VIVO | Start-Up | "The Silver Sheet" | Medtech Insight Newsletter, Medtech Insight Reports | IN3 Conferences & Webinars | Strategic Transactions | Transaction Tracker | Medical Devices Today | Health News Daily
Consumer Focus
"The Tan Sheet" | "The Rose Sheet" | Over the Counter Today | Health News Daily
Specialties
Biotechnology Industry, Pharmaceutical Industry, Medical Device Industry, Consumer Health Industry, Legislative Affairs, Regulatory and Approval Issues, Business Development, Quality and Manufacturing
New hires at Elsevier Business Intelligence
Elsevier Business Intelligence Company Blog
-
Ranbaxy Records $568 Million Loss For DoJ Penalty; Sees More Predictability In U.S. Business
Feb 24, 2012 -
China, Brazil In Line To Copy UK's NICE For Clinical Drug Guidelines
Feb 24, 2012 -
Japanese Rx Market Grows 7% In 2011; Aricept Tops Sales Ranks
Feb 24, 2012 - Feb 24, 2012
- Feb 23, 2012
Elsevier Business Intelligence Activity on LinkedIn
-
Elsevier Business Intelligence Early Bird $300 discounts end March 16th for EBI's Investment In Innovation (IN3) Medical Device 360° London conference, being held April 25-26, 2012 at the Millennium Gloucester Hotel - register your team to attend today! Confirmed panelists include top-tier bus dev and investment decision makers from Sorin Group, Stryker, Edwards Lifesciences, Philips, Sofinnova Partners, NBGI Ventures, Seroba Bioventures, Earlybird Venture Capital and many more. Read more and start-up companies apply to present here: http://www.in3london.com -
Elsevier Business Intelligence 1 WEEK FROM NOW: EBI's IN3 Medical Device 360° Orlando Conference, Ritz-Carlton Orlando, Grande Lakes - 33 innovative device start-ups confirmed to date to present seeking funding and/or strategic partnership; expert Corporate Buy-Side, Alternative Financing, VC and Clinical Trial Panel Discussions, VC/Large Company Meet-and-Greets, and VC presentations featuring many top-tier device acquirers and investors. Come to Orlando and get a full 360-degree view of your market, opportunities and challenges!
-
Elsevier Business Intelligence Elsevier Business Intelligence Announces Exceptional Line-Up of Speakers for its Investment in Innovation (IN³) Medical Device 360° Conference, February 29 - March 2, 2012 at the Ritz-Carlton Orlando, Grande Lakes.
-
Elsevier Business Intelligence Only 2 weeks away: Elsevier Business Intelligence's Investment In Innovation (IN³) Medical Device 360° conference, at the beautiful Ritz-Carlton Orlando Grande Lakes in Orlando, Florida, Feb. 29th to Mar. 2nd. The program will feature presentations by 25+ innovative device start-ups seeking investment or partnership, and a full roster of timely and informative expert workshops and panels. There's still time to register your team to attend this exceptional device investment and partnering event!
-
Elsevier Business Intelligence Elsevier Business Intelligence's Investment In Innovation (IN3) Medical Device 360° Orlando conference, being held Feb. 29-Mar 2, Ritz-Carlton Orlando, Grande Lakes - the event brochure is now available for download: http://www.in3orlando.com/IN3ORLANDO12/IN3OR12-Brochure-Web.pdf - don't miss this powerful medtech investment and partnering event that will benefit all players in the device space.
-
Elsevier Business Intelligence 3 weeks to go until EBI's lN3 Medical Device 360° conference at the Ritz-Carlton Orlando - Exceptional program will benefit all players in the device space; investors in attendance will include senior-level decision makers from Medtronic, Covidien, BD Medical, Baird Venture Partners, Aisling Capital, Accuitive Medical Ventures, Lumira Capital, Early Stage Partners, Thomas McNerney & Partners, LifeLine Ventures, and many others. Register your team today!
-
Elsevier Business Intelligence Make plans today to join us at EBI's lN3 Medical Device 360° conference at the Ritz-Carlton Grande Lakes Orlando, Feb. 29th-Mar 2nd - room rate discount expires this Friday! Exceptional program will benefit all players in the device space; investors in attendance will include senior-level decision makers from Medtronic, Covidien, BD Medical, Baird Venture Partners, Aisling Capital, Accuitive Medical Ventures, Lumira Capital, Early Stage Partners, Thomas McNerney & Partners, LifeLine Ventures, and many others. Register your team today!
-
Elsevier Business Intelligence Elsevier Business Intelligence announces that William Maisel, Deputy Center Director for Science and Chief Scientist at the CDRH/FDA will participate in a Clinical Trials panel on March 2nd at IN3 Medical Device 360° Orlando entitled, "FDA Hot Topics: Clinical Trials and Risk/Benefit Analysis" - see http://www.in3orlando.com for full event information.
-
Elsevier Business Intelligence Apply To Become A Presenter At The Best Networking Conferences Pharmaceutical Strategic Outlook and Euro-Biotech Partnering Summit are designed to connect biotech entrepreneurs with pharma executives and financial leaders interested in investment, partnership, or M&A opportunities. The events will also feature panels, plenary and fireside chats sessions hosted by industry thought leaders focused on the most critical issues impacting the pharma industry.
-
Elsevier Business Intelligence Only one month to go until EBI's lN3 Medical Device 360° conference at the Ritz-Carlton Orlando: Feb. 29-Mar 2. Innovative start-ups taking the stage seeking funding/partnership include molecular diagnostics, bioabsorbable implant, imaging, asthma, diabetes, glaucoma, ophthalmology, urology, organ transplant, polymer and pain management companies, among many others. Program also packed with expert dealmaking and clinical/regulatory panels, and meet-and-greets discussing the most pressing issues facing our global industry in 2012 and beyond. Register your team today!
